|
GB0822170D0
|
|
Telmisartan with diuretic formulations
|
|
GB0822171D0
|
|
Temisartan formulations
|
|
GB0813628D0
|
|
Stable coated anti-cancer agent
|
|
GB0712220D0
|
|
Duloxetine formulation
|
|
GB0616794D0
|
|
Solid dosage form
|
|
CN101263114A
|
|
Crystalline and amorphous sodium atorvastatin
|
|
EP1928823A1
|
|
Process for preparing crystalline sodium salt of ATORVASTATIN
|
|
WO2007020421A1
|
|
Crystalline and amorphous sodium atorvastatin
|
|
GB0613566D0
|
|
Crystalline sodium atorvastatin
|
|
GB0613567D0
|
|
Crystalline sodium atorvastatin
|
|
GB0612506D0
|
|
Crystalline duloxetine hydrochloride
|
|
GB0612508D0
|
|
Crystalline duloxetine hydrochloride
|
|
GB0612509D0
|
|
Crystalline duloxetine hydrochloride
|
|
GB0604141D0
|
|
Nebulizer formulation
|
|
WO2006051287A1
|
|
Composition and method for treatment of alopecia areata
|
|
GB0522047D0
|
|
Ramipril formulations
|
|
GB0521529D0
|
|
Ramipril formulation
|
|
GB0518129D0
|
|
Ramipril formulation
|
|
US2006177610A1
|
|
Sealing of Plastic Containers
|
|
GB0514795D0
|
|
Composition and method for treatment of alopecia areata
|
